A detailed history of State Of Alaska, Department Of Revenue transactions in Exelixis, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 126,842 shares of EXEL stock, worth $4.27 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
126,842
Previous 125,387 1.16%
Holding current value
$4.27 Million
Previous $2.82 Million 16.83%
% of portfolio
0.03%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$21.96 - $27.6 $31,951 - $40,158
1,455 Added 1.16%
126,842 $3.29 Million
Q2 2024

Aug 05, 2024

SELL
$20.34 - $23.73 $24,814 - $28,950
-1,220 Reduced 0.96%
125,387 $2.82 Million
Q1 2024

Apr 19, 2024

SELL
$20.17 - $23.93 $13,715 - $16,272
-680 Reduced 0.53%
126,607 $3 Million
Q4 2023

Jan 19, 2024

BUY
$19.25 - $24.13 $1.72 Million - $2.16 Million
89,436 Added 236.28%
127,287 $3.05 Million
Q3 2023

Oct 16, 2023

SELL
$19.04 - $22.74 $47,695 - $56,963
-2,505 Reduced 6.21%
37,851 $827,000
Q2 2023

Jul 24, 2023

SELL
$18.17 - $20.48 $78,367 - $88,330
-4,313 Reduced 9.66%
40,356 $771,000
Q1 2023

Apr 17, 2023

SELL
$16.3 - $19.41 $7,824 - $9,316
-480 Reduced 1.06%
44,669 $867,000
Q4 2022

Jan 11, 2023

BUY
$14.96 - $17.39 $7,554 - $8,781
505 Added 1.13%
45,149 $724,000
Q3 2022

Oct 20, 2022

SELL
$15.68 - $22.27 $22,971 - $32,625
-1,465 Reduced 3.18%
44,644 $700,000
Q2 2022

Jul 08, 2022

BUY
$17.44 - $23.16 $27,468 - $36,477
1,575 Added 3.54%
46,109 $959,000
Q1 2022

Apr 14, 2022

SELL
$17.03 - $22.67 $21,457 - $28,564
-1,260 Reduced 2.75%
44,534 $1.01 Million
Q4 2021

Jan 12, 2022

SELL
$15.84 - $21.88 $40,471 - $55,903
-2,555 Reduced 5.28%
45,794 $837,000
Q3 2021

Oct 07, 2021

SELL
$16.3 - $21.14 $6,096 - $7,906
-374 Reduced 0.77%
48,349 $1.02 Million
Q2 2021

Jul 12, 2021

SELL
$17.95 - $25.56 $502 - $715
-28 Reduced 0.06%
48,723 $887,000
Q1 2021

Apr 09, 2021

SELL
$20.53 - $25.22 $34,572 - $42,470
-1,684 Reduced 3.34%
48,751 $1.1 Million
Q4 2020

Jan 08, 2021

SELL
$18.39 - $24.8 $42,002 - $56,643
-2,284 Reduced 4.33%
50,435 $1.01 Million
Q3 2020

Oct 05, 2020

SELL
$20.67 - $26.94 $37,454 - $48,815
-1,812 Reduced 3.32%
52,719 $1.29 Million
Q2 2020

Jul 06, 2020

BUY
$16.46 - $27.42 $36,063 - $60,077
2,191 Added 4.19%
54,531 $1.29 Million
Q1 2020

Apr 06, 2020

BUY
$14.46 - $21.8 $34,732 - $52,363
2,402 Added 4.81%
52,340 $901,000
Q4 2019

Jan 07, 2020

SELL
$15.15 - $18.89 $58,963 - $73,519
-3,892 Reduced 7.23%
49,938 $879,000
Q3 2019

Oct 02, 2019

BUY
$17.68 - $22.65 $344,477 - $441,312
19,484 Added 56.73%
53,830 $951,000
Q2 2019

Jul 23, 2019

BUY
$18.93 - $24.75 $2,328 - $3,044
123 Added 0.36%
34,346 $733,000
Q1 2019

Apr 09, 2019

SELL
$19.6 - $24.76 $39,200 - $49,520
-2,000 Reduced 5.52%
34,223 $814,000
Q4 2018

Jan 10, 2019

BUY
$13.65 - $21.8 $3,972 - $6,343
291 Added 0.81%
36,223 $712,000
Q3 2018

Oct 09, 2018

BUY
$15.87 - $22.4 $4,475 - $6,316
282 Added 0.79%
35,932 $636,000
Q2 2018

Jul 10, 2018

BUY
$18.56 - $22.45 $161,286 - $195,090
8,690 Added 32.23%
35,650 $767,000
Q1 2018

Apr 19, 2018

BUY
$22.15 - $31.89 $125,368 - $180,497
5,660 Added 26.57%
26,960 $597,000
Q4 2017

Jan 19, 2018

BUY
$24.23 - $30.93 $516,099 - $658,809
21,300
21,300 $647,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.8B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.